Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome

Drug Discovery Today

Volumn 19, Issue 5, 2014, Pages 579-589

  Zhang, Jun ^a   Li, Yang ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; FIBROBLAST GROWTH FACTOR 21; MONOCLONAL ANTIBODY; FIBROBLAST GROWTH FACTOR;

DIABETES MELLITUS; DRUG TARGETING; METABOLIC SYNDROME X; OBESITY; PROTEIN ENGINEERING; REVIEW; ANIMAL; DRUG EFFECTS; ENDOCRINE SYSTEM; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; ENDOCRINE SYSTEM; FIBROBLAST GROWTH FACTORS; HUMANS; METABOLIC SYNDROME X; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84901496215     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.10.021     Document Type: Review

References (105)

1. T. Inagaki et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell Metab. 5 2007 415 425
2. M.J. Potthoff et al. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response Proc. Natl. Acad. Sci. U. S. A. 106 2009 10853 10858
3. P.A. Dutchak et al. Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones Cell 148 2012 556 567
4. A. Kharitonenkov et al. FGF-21 as a novel metabolic regulator J. Clin. Invest. 115 2005 1627 1635
5. A. Kharitonenkov et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781
6. T. Coskun et al. Fibroblast growth factor 21 corrects obesity in mice Endocrinology 149 2008 6018 6027
7. J. Xu et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice Diabetes 58 2009 250 259
8. D.M. Ornitz, and N. Itoh Fibroblast growth factors Genome Biol. 2 2001 REVIEWS3005
9. Z. Galzie et al. Fibroblast growth factors and their receptors Biochem. Cell Biol. 75 1997 669 685
10. H. Ohuchi et al. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development Biochem. Biophys. Res. Commun. 277 2000 643 649
11. A. Bhushan et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis Development 128 2001 5109 5117
12. M. Konishi et al. Fibroblast growth factor-16 is a growth factor for embryonic brown adipocytes J. Biol. Chem. 275 2000 12119 12122
13. B. Angelin et al. Circulating fibroblast growth factors as metabolic regulators - a critical appraisal Cell Metab. 16 2012 693 705
14. R. Goetz et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members Mol. Cell Biol. 27 2007 3417 3428
15. E.D. Berglund et al. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity Endocrinology 150 2009 4084 4093
16. J. Xu et al. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models - association with liver and adipose tissue effects Am. J. Physiol. Endocrinol. Metab. 297 2009 1105 1114
17. X. Ding et al. betaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism Cell Metab. 16 2012 387 393
18. Y. Zhang et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice Elife 1 2012 e00065
19. M.K. Badman et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell Metab. 5 2007 426 437
20. T. Lundasen et al. PPARalpha is a key regulator of hepatic FGF21 Biochem. Biophys. Res. Commun. 360 2007 437 440
21. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr. Rev. 20 1999 649 688
22. T. Inagaki et al. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21 Cell Metab. 8 2008 77 83
23. S. Wu et al. Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate J. Biol. Chem. 287 2012 26060 26067
24. E.S. Muise et al. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states Mol. Pharmacol. 74 2008 403 412
25. H. Wang et al. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes Mol. Cell Biol. 28 2008 188 200
26. X. Zhang et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans Diabetes 57 2008 1246 1253
27. K. Oishi et al. Time-imposed daily restricted feeding induces rhythmic expression of Fgf21 in white adipose tissue of mice Biochem. Biophys. Res. Commun. 412 2011 396 400
28. J.S. Moyers et al. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling J. Cell. Physiol. 210 2007 1 6
29. W. Wei et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma Proc. Natl. Acad. Sci. U. S. A. 109 2012 3143 3148
30. A.C. Adams et al. Fibroblast growth factor 21 is not required for the antidiabetic actions of thiazolidinediones Mol. Metabolism 2 2013 205 214
31. K.H. Kim et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine Nat. Med. 19 2013 83 92
32. A.N. Plotnikov et al. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity Cell 101 2000 413 424
33. D.E. Johnson, and L.T. Williams Structural and functional diversity in the FGF receptor multigene family Adv. Cancer Res. 60 1993 1 41
34. R. Flaumenhaft et al. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor J. Cell Biol. 111 1990 1651 1659
35. H. Kurosu, and O.M. Kuro The Klotho gene family as a regulator of endocrine fibroblast growth factors Mol. Cell. Endocrinol. 299 2009 72 78
36. H. Kurosu, and M. Kuro-o The Klotho gene family and the endocrine fibroblast growth factors Curr. Opin. Nephrol. Hypertens. 17 2008 368 372
37. X. Wu et al. Co-receptor requirements for fibroblast growth factor-19 signaling J. Biol. Chem. 282 2007 29069 29072
38. Y. Ogawa et al. BetaKlotho is required for metabolic activity of fibroblast growth factor 21 Proc. Natl. Acad. Sci. U. S. A. 104 2007 7432 7437
39. H. Kurosu et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 J. Biol. Chem. 282 2007 26687 26695
40. A. Kharitonenkov et al. FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho J. Cell. Physiol. 215 2008 1 7
41. M. Suzuki et al. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c Mol. Endocrinol. 22 2008 1006 1014
42. X. Wu et al. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors J. Biol. Chem. 283 2008 33304 33309
43. K. Tomiyama et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo Proc. Natl. Acad. Sci. U. S. A. 107 2010 1666 1671
44. A.C. Adams et al. FGF21 requires betaklotho to act in vivo PLoS One 7 2012 e49977
45. J. Yie et al. FGF21 N- and C-termini play different roles in receptor interaction and activation FEBS Lett. 583 2009 19 24
46. R. Micanovic et al. Different roles of N- and C-termini in the functional activity of FGF21 J. Cell. Physiol. 219 2009 227 234
47. X. Wu et al. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation J. Biol. Chem. 285 2010 5165 5170
48. H. Ge et al. Characterization of a FGF19 variant with altered receptor specificity revealed a central role for FGFR1c in the regulation of glucose metabolism PLoS One 7 2012 e33603
49. A.L. Wu et al. Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1 Sci. Transl. Med. 3 2011 113ra126
50. I.N. Foltz et al. Treating diabetes and obesity with an FGF21-mimetic antibody activating the betaKlotho/FGFR1c receptor complex Sci. Transl. Med. 4 2012 162ra153
51. A.C. Adams et al. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue Mol. Metabolism 2 2013 31
52. C. Yang et al. Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress Nutr. Metab. (Lond.) 9 2012 94
53. K. Fon Tacer et al. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse Mol. Endocrinol. 24 2010 2050 2064
54. A.L. Wu et al. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways PLoS One 6 2011 e17868
55. Z. Hu et al. Expression of fibroblast growth factor receptors flg and bek during hepatic ontogenesis and regeneration in the rat Cell Growth Differ. 6 1995 1019 1025
56. Y. Hotta et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver Endocrinology 150 2009 4625 4633
57. W.L. Holland et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice Cell Metab. 17 2013 790 797
58. Z. Lin et al. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice Cell Metab. 17 2013 779 789
59. W. Wente et al. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways Diabetes 55 2006 2470 2478
60. So, W.Y. et al. (2013) High glucose represses beta-Klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor gamma signaling. Diabetes [Epub ahead of print].
61. H. Hsuchou et al. The fasting polypeptide FGF21 can enter brain from blood Peptides 28 2007 2382 2386
62. B.K. Tan et al. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity Diabetes 60 2011 2758 2762
63. D.A. Sarruf et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats Diabetes 59 2010 1817 1824
64. A. Planavila et al. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice Nat. Commun. 4 2013 2019
65. P. Arner et al. FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity FEBS Lett. 582 2008 1725 1730
66. X. Li et al. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice FEBS Lett. 583 2009 3230 3234
67. F.M. Fisher et al. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis Genes Dev. 26 2012 271 281
68. I. Shimomura et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy Genes Dev. 12 1998 3182 3194
69. M. Veniant et al. FGF21 promotes metabolic homeostasis via white adipose and leptin in mice PLoS One 7 2012 e40164
70. X. Wu, and Y. Li Therapeutic utilities of fibroblast growth factor 19 Expert Opin. Ther. Targets 15 2011 1307 1316
71. T. Maack et al. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review Kidney Int. 16 1979 251 270
72. J. Xu et al. Polyethylene glycol modified FGF21 engineered to maximize potency and minimize vacuole formation Bioconjug. Chem. 24 2013 915 925
73. Z. Huang et al. A better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycol PLoS One 6 2011 e20669
74. J. Mu et al. FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents Diabetes 61 2012 505 512
75. H. Cho et al. Optimized clinical performance of growth hormone with an expanded genetic code Proc. Natl. Acad. Sci. U. S. A. 108 2011 9060 9065
76. A. Bendele et al. Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins Toxicol. Sci. 42 1998 152 157
77. B. Bolon et al. Cytoplasmic vacuoles in renal tubular epithelium of mice given polyethylene glycol (PEG) conjugated protein are reduced by altering PEG size and conformation Toxicologist 60 2001 376
78. R. Hecht et al. Rationale-based engineering of a potent long-acting FGF21 analog for the treatment of type 2 diabetes PLoS One 7 2012 e49345
79. T. Hager et al. Differential enzyme-linked immunosorbent assay and ligand-binding mass spectrometry for analysis of biotransformation of protein therapeutics: application to various FGF21 modalities Anal. Chem. 85 2013 2731 2738
80. M. Veniant et al. Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys Endocrinology 153 2012 4192 4203
81. J. Huang et al. Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody J. Pharmacol. Exp. Ther. 346 2013 270 280
82. R. Smith et al. A novel approach to improve the function of FGF21 BioDrugs 27 2013 159 166
83. R. Goetz et al. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands Mol. Cell. Biol. 32 2012 1944 1954
84. A. Kharitonenkov et al. Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319 PLoS One 8 2013 e58575
85. X.L. Ye et al. [Optimization and characterization of a novel FGF21 mutant] Yao Xue Xue Bao 47 2012 897 903
86. X. Wu, and Y. Li Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities Adv. Exp. Med. Biol. 728 2012 195 213
87. L. Fu et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes Endocrinology 145 2004 2594 2603
88. X. Wu et al. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19) Proc. Natl. Acad. Sci. U. S. A. 107 2010 14158 14163
89. K. Nicholes et al. A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice Am. J. Pathol. 160 2002 2295 2307
90. D.M. French et al. Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models PLoS One 7 2012 e36713
91. X. Wu et al. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice Proc. Natl. Acad. Sci. U. S. A. 106 2009 14379 14384
92. S.A. Jones Physiology of FGF15/19 Adv. Exp. Med. Biol. 728 2012 171 182
93. C. Yang et al. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB PLoS One 7 2012 e33870
94. R. Pai et al. Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys Toxicol. Sci. 126 2012 446 456
95. S. Fukumoto, and T. Yamashita FGF23 is a hormone-regulating phosphate metabolism - unique biological characteristics of FGF23 Bone 40 2007 1190 1195
96. I. Urakawa et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23 Nature 444 2006 770 774
97. H. Kurosu et al. Regulation of fibroblast growth factor-23 signaling by Klotho J. Biol. Chem. 281 2006 6120 6123
98. X. Wu et al. A unique FGF23 with the ability to activate FGFR signaling through both alphaKlotho and betaKlotho J. Mol. Biol. 418 2012 82 89
99. R. Goetz et al. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor J. Biol. Chem. 287 2012 29134 29146
100. S. Ussar et al. Receptor antibodies as novel therapeutics for diabetes Sci. Transl. Med. 3 2011 113ps47
101. A.L. Wu et al. Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia PLoS One 8 2013 e57322
102. N.J. Harmer et al. Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex J. Mol. Biol. 339 2004 821 834
103. J. Yie et al. Understanding the physical interactions in the FGF21/FGFR/beta-Klotho complex: structural requirements and implications in FGF21 signaling Chem. Biol. Drug Des. 79 2012 398 410
104. J. Gupte et al. The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21 J. Mol. Biol. 408 2011 491 502
105. R. Smith et al. FGF21 can be mimicked in vitro and in vivo by a novel anti-FGFR1c/beta-Klotho bispecific protein PLoS One 8 2013 e61432